• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Cardiovascular, Kidney, and Metabolic Syndrome Highly Prevalent in the U.S.

Medically reviewed by Carmen Pope, BPharm. Last updated on May 10, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 10, 2024 -- Cardiovascular, kidney, and metabolic (CKM) syndrome is highly prevalent in the United States, with more than 90 percent of adults meeting the criteria for stage 1 or higher, according to a research letter published online May 8 in the Journal of the American Medical Association.

Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues examined the prevalence and temporal evolution of CKM syndrome stages using the National Health and Nutrition Examination Survey (2011 to March 2020). A total of 10,762 adults were included as the final study population.

The researchers found that between 2011 and 2020, 10.6, 25.9, 49.0, 5.4, and 9.2 percent of U.S. adults met the criteria for stage 0, 1, 2, 3, and 4, respectively. During the study period, there was no significant change in the prevalence of each stage. Advanced stages occurred in 14.6 percent of U.S. adults, with no significant change during the study period. Compared with adults aged 45 through 64 years and those aged 20 through 44 years, adults aged 65 years and older were more likely to have advanced stages (55.3 percent versus 10.7 and 2.1 percent, respectively). Stage 0 occurred in 18.2 percent of those aged 20 through 44 years. Men were more likely than women to have advanced stages (16.9 versus 12.4 percent; adjusted prevalence ratio, 1.36), as were Black versus White adults (18.9 versus 13.8 percent; adjusted prevalence ratio, 1.38).

"Poor CKM health is widespread in the U.S. population, especially among Black adults," the authors write. "Equitable health care approaches prioritizing CKM health are urgently needed."

Two authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.